OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

KYOWA KIRIN CO. LTD./  JP3256000005  /

gettex
2024-05-17  9:43:35 PM Chg. -0.200 Volume Bid2024-05-17 Ask2024-05-17 Market Capitalization Dividend Y. P/E Ratio
15.600EUR -1.27% 18
Turnover: 282.400		 15.200Bid Size: 162 15.600Ask Size: 162 8.29 bill.EUR - -
GlobeNewswire 05-16 Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire 05-15 Lantheus Announces Executive Appointments to Accelerate Innovation
GlobeNewswire 05-14 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 05-08 Pharming Group reports first quarter 2024 financial results and provides business update
GlobeNewswire 05-07 Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Ir...
GlobeNewswire 05-07 Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
GlobeNewswire 05-03 Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024...
GlobeNewswire 05-02 Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-02 Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 05-02 BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswire 05-01 Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Ch...
GlobeNewswire 04-23 AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval...
GlobeNewswire 04-18 Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
GlobeNewswire 04-10 Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as Pr...
GlobeNewswire 03-28 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 03-25 Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate ...
GlobeNewswire 03-20 Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Ap...
GlobeNewswire 03-18 Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy ...
GlobeNewswire 03-14 Pharming Group reports fourth quarter and full year 2023 financial results
GlobeNewswire 03-12 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 02-27 Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
GlobeNewswire 02-22 Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire 02-22 BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
GlobeNewswire 02-19 InveniAI Announces Collaboration with Ono Pharmaceutical for Target Discovery
GlobeNewswire 02-15 Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update